Details of the Drug Reposition

General Information of This Drug (ID: DMNU3SI)

Drug Name
GSK180   DMNU3SI
Synonyms
1799725-26-0; CHEMBL4092205; 3-(5,6-dichloro-2-oxo-1,3-benzoxazol-3-yl)propanoic acid; 3-(5,6-Dichloro-2-Oxobenzo[d]oxazol-3(2h)-Yl)propanoic Acid; JHY; GTPL9007; SCHEMBL16836556; GSK-180; BCP33987; EX-A4035; GSK 180; GSK-180; BDBM50266036; SB19707; inhibitor A1 [PMID: 28604669]; HY-112179; CS-0043620; ClC=1C(=CC2=C(N(C(O2)=O)CCC(=O)O)C1)Cl; Q27077878
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Preclinical Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neurodegenerative disorder DIS8VTJW 8A20-8A23 Preclinical [1]
Pancreatitis DIS0IJEF DC31-DC34 Preclinical [1]
------------------------------------------------------------------------------------

References

1 Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019 May;18(5):379-401.